Microsurgery for the treatment of primary malignant intracranial melanoma: A surgical series and literature review

European Journal of Surgical Oncology

Volumn 40, Issue 9, 2014, Pages 1062-1071

  Wang, J ^a   Guo, Z Z ^a   Wang, Y J ^a   Zhang, S G ^a   Xing, D G ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Chemotherapy; Melanoma; Microsurgery; Radiotherapy

Indexed keywords

CHEMOTHERAPY; MELANOMA; MICROSURGERY; RADIOTHERAPY;

ADULT; AGED; BRAIN; BRAIN NEOPLASMS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MELANOMA; MICROSURGERY; MIDDLE AGED; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84905924219     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2013.11.024     Document Type: Article

References (38)

1. S.V. Liubinas, N. Maartens, and K.J. Drummond Primary melanocytic neoplasms of the central nervous system J Clin Neurosci 17 10 2010 1227 1232
2. A.E. Sloan, C.J. Nock, and D.B. Einstein Diagnosis and treatment of melanoma brain metastasis: a literature review Cancer Control 16 3 2009 248 255
3. J.S. Barnholtz-Sloan, A.E. Sloan, and F.G. Davis et al. Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System J Clin Oncol 22 14 2004 2865 2872
4. D. Bafaloukos, and H. Gogas The treatment of brain metastases in melanoma patients Cancer Treat Rev 30 6 2004 515 520
5. D. Freudenstein, A. Wagner, and A. Bornemann et al. Primary melanocytic lesions of the CNS: report of five cases Zentralbl Neurochir 65 3 2004 146 153
6. A. Barth, L.A. Wanek, and D.L. Morton Prognostic factors in 1,521 melanoma patients with distant metastases J Am Coll Surg 181 3 1995 193 201
7. K.M. Fife, M.H. Colman, and G.N. Stevens et al. Determinants of outcome in melanoma patients with cerebral metastases J Clin Oncol 22 7 2004 1293 1300
8. I. Isiklar, N.E. Leeds, G.N. Fuller, and A.J. Kumar Intracranial metastatic melanoma: correlation between MR imaging characteristics and melanin content AJR Am J Roentgenol 165 6 1995 1503 1512
9. A. Guzel, J. Maciaczyk, and H. Dohmen-Scheufler et al. Multiple intracranial melanoma metastases: case report and review of the literature J Neurooncol 93 3 2009 413 420
10. E.M. Marchan, and J. Sheehan Stereotactic radiosurgery of brain metastasis from melanoma Prog Neurol Surg 25 2 2012 176 189
11. A. Jawahar, M. Shaya, and P. Campbell et al. Role of stereotactic radiosurgery as a primary treatment option in the management of newly diagnosed multiple (3-6) intracranial metastases Surg Neurol 64 3 2005 207 212
12. A. Jawahar, B.K. Willis, D.R. Smith, F. Ampil, R. Datta, and A. Nanda Gamma knife radiosurgery for brain metastases: do patients benefit from adjuvant external-beam radiotherapy? An 18-month comparative analysis Stereotact Funct Neurosurg 79 3-4 2002 262 271
13. A. Muacevic, B. Wowra, A. Siefert, J.C. Tonn, H.J. Steiger, and F.W. Kreth Microsurgery plus whole brain irradiation versus Gamma Knife surgery alone for treatment of single metastases to the brain: a randomized controlled multicentre phase III trial J Neurooncol 87 3 2008 299 307
14. D.W. Andrews, C.B. Scott, and P.W. Sperduto et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial Lancet 363 9422 2004 1665 1672
15. H. Aoyama, H. Shirato, and M. Tago et al. Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial JAMA 295 21 2006 2483 2491
16. H.J. Gogas, J.M. Kirkwood, and V.K. Sondak Chemotherapy for metastatic melanoma: time for a change? Cancer 109 3 2007 455 464
17. D.G. Perez, V.J. Suman, and T.R. Fitch et al. Phase 2 trial of carboplatin, weekly paclitaxel, and biweekly bevacizumab in patients with unresectable stage IV melanoma: a North Central Cancer Treatment Group study, N047A Cancer 115 1 2009 119 127
18. L.A. Kottschade, V.J. Suman, and T. Amatruda 3rd et al. A phase II trial of nab-paclitaxel (ABI-007) and carboplatin in patients with unresectable stage IV melanoma: a North Central Cancer Treatment Group Study, N057E(1) Cancer 117 8 2011 1704 1710
19. F.S. Hodi, S.J. O'Day, and D.F. McDermott et al. Improved survival with ipilimumab in patients with metastatic melanoma N Engl J Med 363 8 2010 711 723
20. C. Robert, L. Thomas, and I. Bondarenko et al. Ipilimumab plus dacarbazine for previously untreated metastatic melanoma N Engl J Med 364 26 2011 2517 2526
21. P.B. Chapman, A. Hauschild, and C. Robert et al. Improved survival with vemurafenib in melanoma with BRAF V600E mutation N Engl J Med 364 26 2011 2507 2516
22. D.G. Shapiro, and W.E. Samlowski Management of melanoma brain metastases in the era of targeted therapy J Skin Cancer 2011 845863
23. G.T. Gibney, P.A. Forsyth, and V.K. Sondak Melanoma in the brain: biology and therapeutic options Melanoma Res 22 3 2012 177 183
24. S. Jaiswal, M. Vij, A. Tungria, A.K. Jaiswal, A.K. Srivastava, and S. Behari Primary melanocytic tumors of the central nervous system: a neuroradiological and clinicopathological study of five cases and brief review of literature Neurol India 59 3 2011 413 419
25. N. Ramakrishna, and K.A. Margolin Multidisciplinary approach to brain metastasis from melanoma; local therapies for central nervous system metastases Am Soc Clin Oncol Educ Book 2013 2013 399 403
26. R. Partl, E. Richtig, A. Avian, A. Berghold, and K.S. Kapp Karnofsky performance status and lactate dehydrogenase predict the benefit of palliative whole-brain irradiation in patients with advanced intra- and extracranial metastases from malignant melanoma Int J Radiat Oncol Biol Phys 85 3 2012 662 666
27. M.G. Ewend, D.E. Morris, L.A. Carey, A.M. Ladha, and S. Brem Guidelines for the initial management of metastatic brain tumors: role of surgery, radiosurgery, and radiation therapy J Natl Compr Canc Netw 6 5 2008 505 513
28. M.M. Konstadoulakis, E. Messaris, G. Zografos, G. Androulakis, and C. Karakousis Prognostic factors in malignant melanoma patients with solitary or multiple brain metastases. Is there a role for surgery? J Neurosurg Sci 44 4 2000 211 218
29. M. Kocher, R. Soffietti, and U. Abacioglu et al. Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study J Clin Oncol 29 2 2011 134 141
30. E. Alexander III, T.M. Moriarty, and R.B. Davis et al. Stereotactic radiosurgery for the definitive, noninvasive treatment of brain metastases J Natl Cancer Inst 87 1 1995 34 40
31. J.C. Flickinger, D. Kondziolka, and L.D. Lunsford et al. A multi-institutional experience with stereotactic radiosurgery for solitary brain metastasis Int J Radiat Oncol Biol Phys 28 4 1994 797 802
32. J.J. Hong, S.A. Rosenberg, and M.E. Dudley et al. Successful treatment of melanoma brain metastases with adoptive cell therapy Clin Cancer Res 16 19 2010 4892 4898
33. S.S. Agarwala, J.M. Kirkwood, and M. Gore et al. Temozolomide for the treatment of brain metastases associated with metastatic melanoma: a phase II study J Clin Oncol 22 11 2004 2101 2107
34. L.M. Guirguis, J.C. Yang, and D.E. White et al. Safety and efficacy of high-dose interleukin-2 therapy in patients with brain metastases J Immunother 25 1 2002 82 87
35. S. Powell, and A.Z. Dudek Single-institution outcome of high-dose interleukin-2 (HD IL-2) therapy for metastatic melanoma and analysis of favorable response in brain metastases Anticancer Res 29 10 2009 4189 4193
36. A.M. Di Giacomo, P.A. Ascierto, and E. Fonsatti et al. Ipilimumab and fotemustine in patients with advanced melanoma (NIBIT-M1): an open-label, single-arm phase 2 trial Lancet Oncol 13 9 2012 879 886
37. J.M. Kirkwood, L. Bastholt, and C. Robert et al. Phase II, open-label, randomized trial of the MEK1/2 inhibitor selumetinib as monotherapy versus temozolomide in patients with advanced melanoma Clin Cancer Res 18 2 2012 555 567
38. N.M. Rochet, R.S. Dronca, and L.A. Kottschade et al. Melanoma brain metastases and vemurafenib: need for further investigation Mayo Clin Proc 87 10 2012 976 981